双层探测器CT虚拟单能图像用于乳腺癌术前分期的临床可行性:与乳腺MRI的比较
本研究纳入152例患者共155个指标乳腺癌,评估增强胸部双层探测器CT(DLCT)40 keV虚拟单能图像(VMI)三维最大密度投影(MIP)用于术前分期的可行性,并与乳腺MRI比较。结果显示DLCT检出率84.5%(131/155)与MRI 88.4%(137/155)无显著差异(P=0.210),肿瘤大小测量一致性良好,提示DLCT可作为乳腺MRI禁忌患者的潜在替代方案。
要点
- DLCT 40 keV VMI三维MIP对乳腺癌检出率84.5%,与乳腺MRI 88.4%无显著差异(P=0.210)。
- DLCT与MRI肿瘤大小测量平均差-0.05 cm,95%一致性界限-1.29至1.19 cm。
- DLCT测肿瘤大小2.3±1.7 cm与MRI 2.4±1.6 cm无显著差异(P=0.106)。
核心结论
- 胸部DLCT VMI用于乳腺癌术前分期具有可行性,肿瘤检出率和大小测量与乳腺MRI相当,可能作为乳腺MRI禁忌患者的潜在替代方案。
研究设计与样本
- 研究纳入152例患者共155个指标乳腺癌,采用增强胸部DLCT 40 keV VMI三维MIP与乳腺MRI对比,由两名放射科医师间隔3个月分别共识阅片。
诊断标准与关键数值
- DLCT 40 keV VMI对指标乳腺癌检出率为84.5%(131/155),乳腺MRI为88.4%(137/155),P=0.210。
- DLCT与MRI肿瘤大小测量平均差-0.05 cm,95%一致性界限-1.29至1.19 cm。
- DLCT测得肿瘤大小2.3±1.7 cm,MRI为2.4±1.6 cm,P=0.106。
临床应用与阅片要点
- 作者认为胸部DLCT VMI可作为乳腺MRI禁忌患者的潜在替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Dual-layer CT (DLCT) can create virtual monochromatic images (VMIs) at various monochromatic X-ray energies, particularly at low keV levels, with high contrast-to-noise ratio. The purpose of this study was to assess the clinical feasibility of contrast-enhanced chest DLCT with a low keV VMI for preoperative breast cancer staging, in comparison to breast MRI.
MATERIALS AND METHODS: A total of 152 patients with 155 index breast cancers were enrolled in the study. VMIs were generated from contrast-enhanced chest DLCT at 40 keV and maximum intensity projection (MIP) with three-dimensional (3D) reconstruction was performed for both bilateral breast areas. Two radiologists reviewed in consensus the 3D MIP images of the chest DLCT with VMI and breast MRI in separate sessions with a 3-month wash-out period. The detection rate and mean tumor size of the index cancer were compared between the chest DLCT with VMI and breast MRI. Additionally, the agreement of tumor size measurement between the two imaging modalities were evaluated.
RESULTS: Of all index cancers, 84.5% (131/155) were detected in the chest DLCT with VMI, while 88.4% (137/155) were detected in the breast MRI (P = 0.210). The Bland-Altman agreement between the chest DLCT with VMI and breast MRI was a mean difference of -0.05 cm with 95% limits of agreement of -1.29 to 1.19 cm. The tumor size in the chest DLCT with VMI (2.3 ± 1.7 cm) was not significantly different from that in the breast MRI (2.4 ± 1.6 cm) (P = 0.106).
CONCLUSION: The feasibility of chest DLCT with VMI was demonstrated for preoperative tumor staging in breast cancer patients, showing comparable cancer detectability and good agreement in tumor size measurement compared to breast MRI. This suggests that chest DLCT with VMI can serve as a potential alternative for patients who have contraindications to breast MRI.
引用
- Yeo B, Shin KM, Park B, et al. Clinical Feasibility of Dual-Layer CT With Virtual Monochromatic Image for Preoperative Staging in Patients With Breast Cancer: A Comparison With Breast MRI. Korean J Radiol. 2024. PMID: 39197825. doi:10.3348/kjr.2023.1312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。